A retrospective longitudinal observational study of natural history of ESBL/MDR gram negative organisms in patients hospitalized in a tertiary hospital
Background: The IDSA recommends that when determining empiric treatment for a given patient, clinicians should consider previous organisms and associated antibiotic susceptibility data in the prior 6 months when multidrug-resistant/extended-spectrum β-lactamase gram-negative rods (MDR /ESBL GNR) is...
Saved in:
Main Authors: | Shikha Vasudeva (Author), Anthony Baffoe-Bonnie (Author) |
---|---|
Format: | Book |
Published: |
Cambridge University Press,
2022-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evolution and development of potent monobactam sulfonate candidate IMBZ18g as a dual inhibitor against MDR Gram-negative bacteria producing ESBLs
by: Zhiwen Li, et al.
Published: (2023) -
The "Old" and the "New" Antibiotics for MDR Gram-Negative Pathogens: For Whom, When, and How
by: Ilias Karaiskos, et al.
Published: (2019) -
Activity of Cefepime-Zidebactam against Multidrug-Resistant (MDR) Gram-Negative Pathogens
by: Kenneth S. Thomson, et al.
Published: (2019) -
Plasmid profile of ESBL producing Gram-negative bacteria and correlation with susceptibility to β-lactam drugs
by: Sharma Jyoti, et al.
Published: (2010) -
Elucidating the efficacy of combination therapy and colistin resistance mechanisms in MDR/XDR Gram-negative Bacilli
by: Diana Abdulghani, et al.
Published: (2020)